Marine Drug Research in Korea
A special issue of Marine Drugs (ISSN 1660-3397).
Deadline for manuscript submissions: closed (31 December 2021) | Viewed by 30341
Special Issue Editor
Interests: marine natural products; biomedical applications
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
South Korea is one of the emerging countries in marine drug research. The country has a great marine biodiversity, which is one of the most important sources of chemical diversity and bioactive compounds, even though it has been largely underexplored. Geographically, South Korea is mostly surrounded by sea and has 2413 km of coastline along three seas, which represents a great potential for finding new bioactive marine metabolites. This Special Issue presents studies on marine natural products in Korea, including results obtained by different research groups, with an emphasis on the discovery and development of new metabolites and the evaluation of the biological activities of natural products isolated from Korean marine resources.
As a Guest Editor for this Special Issue, I invite you to submit your research results on marine drug development research for new marine natural products, and the in vitro and in vivo activities of marine secondary metabolites. This Special Issue will also include challenges in drug development from marine sources, especially supply problems, mechanisms of action, and the biosynthesis and total synthesis of marine natural products.
Prof. Hee Jae Shin
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Marine natural products
- Secondary metabolites
- Bioactive compounds
- Drug development
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
Related Special Issue
- Marine Drug Research in Korea II in Marine Drugs (7 articles)